Streetbeat News

Regulatory

NVO

Novo Nordisk CEO Lars Jorgensen testified before the Senate regarding the pricing of weight loss drugs. This event could impact Novo Nordisk's stock as it may influence regulatory and public perception of the company's pricing strategies.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 2:06 pm

CAPR

Capricor Therapeutics Inc (NASDAQ:CAPR) shares surged after announcing plans to file a biologics license application for Deramiocel, targeting Duchenne muscular dystrophy cardiomyopathy. The stock has gained over 55% in a week, bolstered by a European expansion deal and positive analyst ratings.

Portfolio Pulse from Adam Eckert

September 24, 2024 | 2:05 pm

BZ

LBRDA

NIO

TSLA

WVE

Several US-listed stocks saw significant gains on Tuesday. Wave Life Sciences surged 37.9% after positive interim data from a study. Chinese stocks like Kanzhun, Bilibili, and NIO rose due to a new stimulus package from China's Central Bank. Tesla gained 2.5% on strong vehicle registration data from China.

Portfolio Pulse from Avi Kapoor

September 24, 2024 | 1:59 pm

SPY

Fed's Bowman comments on the chilling effect of litigation risk on regulatory agencies following the Chevron ruling, describing it as a positive influence on preventing overreach. Additionally, Bowman notes the difficulty for the Fed in measuring immigration's impact on the labor market.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:56 pm

FXI

NVO

SMAR

China has announced a new economic stimulus package, which could impact global markets. Novo Nordisk's CEO is set to testify before the Senate, potentially affecting the company's stock. Smartsheet is to be acquired by Blackstone and Vista, which is likely to influence its stock price.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:47 pm

LC

QFIN

The People's Bank of China has announced significant stimulus measures to boost the Chinese economy and stock market, including rate cuts and liquidity support. Qifu Technology, Inc. (NASDAQ:QFIN), a Chinese lending platform, is expected to benefit from these measures.

Portfolio Pulse from David Pinsen

September 24, 2024 | 1:40 pm

BABA

FXI

KWEB

LI

NIO

XPEV

Chinese stocks, including Alibaba, NIO, XPeng, and Li Auto, rose after China's central bank cut the reserve requirement ratio and the seven-day reverse repurchase rate. This move, along with a recent U.S. Fed rate cut, is expected to boost growth. Investors can gain exposure through ETFs like FXI and KWEB.

Portfolio Pulse from Anusuya Lahiri

September 24, 2024 | 1:22 pm

BABA

EWH

FXI

JD

KWEB

LI

MCHI

NIO

Chinese stocks and U.S.-listed ETFs investing in Chinese equities surged following a major monetary stimulus from the People's Bank of China, which included cuts to the reserve requirement ratio and repo rates. This move is seen as a proactive step to address economic slowdown concerns.

Portfolio Pulse from Piero Cingari

September 24, 2024 | 1:15 pm

CAPR

Capricor Therapeutics shares rose following the announcement of their plan to file a biologics license application for Deramiocel, aimed at treating Duchenne muscular dystrophy cardiomyopathy.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:09 pm

GOOGL

The UK's Competition and Markets Authority (CMA) has accepted commitments from Google to address concerns regarding its proposals to remove third-party cookies and other functionalities from its Chrome browser.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:08 pm